AusPAR: Wezlana

Australian Public Assessment Report

AusPAR

AusPAR: WEZLANA [PDF, 1.11 MB]

AusPAR: WEZLANA [Word, 3.29 MB]

Attachment Product information for WEZLANA [PDF, 945.53 KB]

Attachment Product information for WEZLANA [Word, 1.1 MB]

Device/Product Name

Wezlana

Active ingredients

Ustekinumab

AusPAR Date

18 June 2024

Published

27 June 2024

Submission Number

PM-2023-00167-1-1

Submission Type

Biosimilar medicine

Decision

Approved